
Addex Therapeutics Ltd
ADXNHealthcare|Biotechnology|CH
$2.90
+0.00 (+0.00%)
DCF Value
$1.41
Tangible Book / Share
$1.31
Cash / Share
$0.53
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Dec 10, 2025 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
ADDEX INCREASES ISSUED SHARE CAPITAL TO CREATE TREASURY SHARES
Oct 29, 2026 · GlobeNewsWire
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
Oct 8, 2026 · GlobeNewsWire
Addex Therapeutics Announces Executive Management Changes
Oct 2, 2026 · GlobeNewsWire
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
Sep 28, 2026 · GlobeNewsWire
Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior
Sep 25, 2026 · GlobeNewsWire
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
Sep 24, 2026 · GlobeNewsWire
ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
Aug 26, 2026 · GlobeNewsWire
SEC Filings (40)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 29, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 2, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 28, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 4, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 27, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 26, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 5, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 15, 2026 | 20-F | Annual report (foreign) | DocumentIndex |
| Apr 30, 2026 | NT 20-F | DocumentIndex | |
| Apr 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 29, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 23, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 21, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 3, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 7, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 10, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 10, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Dec 5, 2025 | EFFECT | DocumentIndex | |
| Dec 4, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Nov 19, 2025 | F-3 | Shelf registration | DocumentIndex |
| Oct 29, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 30, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 23, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 30, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 25, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 23, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 20, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 6, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| May 15, 2025 | 20-F | Annual report (foreign) | DocumentIndex |
| May 12, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 30, 2025 | NT 20-F | DocumentIndex | |
| Apr 30, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 25, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 17, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Nov 22, 2024 | 6-K | Foreign issuer report | DocumentIndex |